EpiBiotech Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
12
- Stock Symbol
-
446440
- Investments
-
1
- Share Price
-
$3.66
- (As of Friday Closing)
EpiBiotech General Information
Description
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.
Contact Information
Website
www.epibiotech.comCorporate Office
- M-Number 1903
- 32, Songdogwahak-ro, Yeonsu-gu
- Incheon, 21984
- South Korea
Corporate Office
- M-Number 1903
- 32, Songdogwahak-ro, Yeonsu-gu
- Incheon, 21984
- South Korea
EpiBiotech Stock Performance
As of 20-Nov-2026, EpiBiotech’s stock price is $3.66. Its current market cap is $8.45M.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.66 | $3.19 | $2.71 - $16.56 | $8.45M | 565.85 | -$0.58 |
EpiBiotech Financials Summary
As of 31-Dec-2025, EpiBiotech has a trailing 12-month revenue of $1.36M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 25,020 | 25,020 | ||
| Revenue | 1,355 | 1,355 | 536 | 217 |
| EBITDA | (45) | (45) | (2,252) | |
| Net Income | (1,342) | (1,342) | (3,576) | |
| Total Assets | 3,679 | 3,679 | 2,455 | 5,357 |
| Total Debt | 1,328 | 1,328 | 1,427 | 0 |
EpiBiotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
EpiBiotech Comparisons
Industry
Financing
Details
EpiBiotech Competitors (2)
One of EpiBiotech’s 2 competitors is 0913693 BC, a Corporation company based in Vancouver, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 0913693 BC | Corporation | Vancouver, Canada | ||||
| Stemsontx | Venture Capital-Backed | CA |
EpiBiotech Patents
EpiBiotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024054006-A1 | Novel genomic safe harbor and use thereof | Inactive | 05-Sep-2022 | ||
| WO-2024010157-A1 | Composition containing hair follicle cells | Inactive | 08-Jul-2022 | ||
| EP-4435003-A1 | Antibody to cxcl 12 and composition comprising same for treatment of hair loss | Pending | 27-Dec-2021 | ||
| EP-4435003-A4 | Antibody to cxcl 12 and composition comprising same for treatment of hair loss | Pending | 27-Dec-2021 | ||
| WO-2023128494-A1 | Antibody to cxcl 12 and composition comprising same for treatment of hair loss | Inactive | 27-Dec-2021 | C07K16/24 |
EpiBiotech Signals
EpiBiotech Investments (1)
EpiBiotech’s most recent deal was a Joint Venture with Joint Venture (Epi Biotech / Northland Biotech). The deal was made on 14-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Epi Biotech / Northland Biotech) | 14-Apr-2025 | Joint Venture | Clinics/Outpatient Services |
EpiBiotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
EpiBiotech FAQs
-
When was EpiBiotech founded?
EpiBiotech was founded in 2015.
-
Where is EpiBiotech headquartered?
EpiBiotech is headquartered in Incheon, South Korea.
-
What is the size of EpiBiotech?
EpiBiotech has 12 total employees.
-
What industry is EpiBiotech in?
EpiBiotech’s primary industry is Drug Discovery.
-
Is EpiBiotech a private or public company?
EpiBiotech is a Public company.
-
What is EpiBiotech’s stock symbol?
The ticker symbol for EpiBiotech is 446440.
-
What is the current stock price of EpiBiotech?
As of 20-Nov-2026 the stock price of EpiBiotech is $3.66.
-
What is the current market cap of EpiBiotech?
The current market capitalization of EpiBiotech is $8.45M.
-
What is EpiBiotech’s current revenue?
The trailing twelve month revenue for EpiBiotech is $1.36M.
-
Who are EpiBiotech’s competitors?
0913693 BC and Stemsontx are competitors of EpiBiotech.
-
What is EpiBiotech’s annual earnings per share (EPS)?
EpiBiotech’s EPS for 12 months was -$0.58.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process